The present study aims to investigate the role of ZNF143 (zinc finger protein 143, the transcription factor of KPNA2) in regulating the effects of KPNA2 on glioma and to explore novel therapeutic targets for glioma. This evidence concerns the gene KPNA2 and central nervous system cancer.